Supernus Pharmaceuticals SUPN Income Statement (2011-2026)

NASDAQ SUPN
$41.90 -0.53 (-1.25%)
As of: Sep 9, 2026 · 12:05 PM EDT
Reported Financials

Supernus Pharmaceuticals Quarterly Income Statement

Periods 62 quarters
Latest Jun 2026

Supernus Pharmaceuticals reported revenue of $219.06M and net income of -$58.37M for the quarter ended Jun 2026, up 32.4% year over year. This income statement covers 62 quarters of results from Mar 2011 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
148.46M159.05M152.51M170.05M177.35M167.33M153.76M135.56M153.88M164.31M143.64M168.32M175.69M174.16M149.82M165.45M192.10M211.57M219.06M
Cost of RevenueCost of Rev
18.09M16.99M17.93M20.46M25.88M22.95M23.46M21.09M19.60M19.63M16.31M17.92M17.58M26.10M15.76M16.83M18.96M23.01M33.67M
Gross Profit
130.38M142.06M134.57M149.59M151.47M144.37M130.30M114.47M134.28M144.69M127.33M150.41M158.11M148.06M134.06M148.63M173.14M188.56M185.39M
Operating items
Amortization - Intangibles
6.01M12.04M20.64M20.64M20.64M20.70M20.00M20.11M21.24M21.08M20.14M20.11M19.50M18.27M19.80M20.82M24.32M24.57M25.33M
Research & DevelopmentR&D
19.65M21.08M20.84M16.39M19.55M17.77M21.21M24.38M22.66M23.35M24.93M26.18M29.04M28.65M26.93M22.11M29.37M27.83M29.46M
Selling, General & AdministrativeSG&A
72.03M101.73M90.46M100.48M112.31M73.97M85.60M86.78M82.70M81.28M86.52M85.90M69.75M79.41M89.94M93.55M179.68M122.39M133.64M
Other Operating ExpensesOther Opex
24.17M30.14M39.24M41.84M47.01M41.25M41.78M41.99M40.39M60.68M35.35M33.67M36.05M44.70M43.21M37.65M43.29M65.29M113.92M
Operating ExpensesOpex
115.86M152.95M150.54M158.71M178.88M132.99M148.59M153.15M145.74M165.31M146.80M145.76M134.84M152.75M160.08M153.31M252.33M215.51M277.02M
Operating IncomeOp. Inc
32.60M6.10M1.97M11.35M-1.52M34.33M5.18M-17.59M8.14M-1.00M-3.15M22.57M40.84M21.41M-10.26M12.14M-60.23M-3.94M-57.96M
EBIT
32.60M6.10M1.97M11.35M-1.52M34.33M5.18M-17.59M8.14M-1.00M-3.15M22.57M40.84M21.41M-10.26M12.14M-60.23M-3.94M-57.96M
Non-operating items
Non Operating Interest Expenses
5.92M5.93M1.94M1.81M1.72M1.59M1.50M0.91M2.31M
Interest & Investment IncomeInt & Inv Inc
0.88M0.55M0.06M0.16M0.03M4.53M-0.21M2.63M
Other Non Operating IncomeOther Non Op Inc.
2.28M-21.54M14.70M1.79M2.80M2.40M5.35M1.37M1.75M1.99M3.40M3.73M4.10M4.98M4.42M4.53M2.28M2.02M
Non Operating IncomeNon Op. Inc.
-3.64M12.76M-0.02M1.08M0.81M3.84M0.46M1.75M1.99M3.40M3.73M4.10M4.98M4.42M4.53M2.28M2.02M0.32M
Net income details
EBT
28.96M2.05M14.72M11.32M-0.44M35.14M9.02M-17.13M9.89M0.99M0.24M26.30M44.94M26.38M-5.83M16.67M-57.95M-1.91M-57.65M
Tax ProvisionsTaxes
7.40M-0.39M-10.90M3.50M-2.20M9.66M-7.93M-16.30M25.90M-0.18M0.12M6.40M6.45M11.01M6.00M-5.83M-12.84M2.22M0.72M
Profit After TaxPAT
21.56M2.44M25.62M7.87M1.75M25.48M16.95M-0.83M-15.98M1.18M0.12M19.92M38.50M15.33M-11.83M22.50M-45.12M-4.11M-2.29M-58.37M
Income from Continuing OperationsIncome (Continuing)
21.56M2.44M25.62M7.82M1.76M25.48M16.95M-0.83M-16.01M1.18M0.12M19.90M38.50M15.38M-11.83M22.50M-45.12M-4.13M-58.37M
Income from Discontinued OperationsIncome (Discontinued)
Consolidated Net IncomeConsol Net Inc.
21.56M2.44M25.62M7.82M1.76M25.48M16.95M-0.83M-16.01M1.18M0.12M19.90M38.50M15.38M-11.83M22.50M-45.12M-4.13M-58.37M
Income towards Parent CompanyParent Net Inc
21.56M2.44M25.62M7.82M1.76M25.48M16.95M-0.83M-16.01M1.18M0.12M19.90M38.50M15.38M-11.83M22.50M-45.12M-4.13M-58.37M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
21.56M2.44M25.62M7.82M1.76M25.48M16.95M-0.83M-16.01M1.18M0.12M19.90M38.50M15.38M-11.83M22.50M-45.12M-4.13M-58.37M
Additional items
EPS (Basic)
0.410.050.480.150.030.470.31-0.02-0.290.020.000.360.700.28-0.210.40-0.80-0.07-1.01
EPS (Diluted)
0.400.040.420.130.030.410.27-0.02-0.290.020.000.360.690.27-0.210.40-0.80-0.07-1.01
Shares Outstanding
53.19M53.10M53.33M53.43M53.79M53.67M54.38M54.50M54.61M54.54M54.80M54.98M55.15M55.10M55.86M56.02M56.55M56.45M57.65M58.07M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
54.33M54.36M61.41M61.40M55.03M61.68M62.45M54.50M54.61M55.51M55.63M55.72M56.02M55.96M55.86M56.64M56.55M56.45M57.65M58.07M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
52.87M53.26M53.26M53.26M53.26M54.25M54.25M54.25M54.25M54.72M54.72M55.05M55.22M55.74M55.99M56.12M57.12M57.46M58.04M58.16M
EBITDA
32.60M6.10M1.97M11.35M-1.52M34.33M5.18M-17.59M8.14M-1.00M-3.15M22.57M40.84M21.41M-10.26M12.14M-60.23M-3.94M-57.96M
Interest ExpensesInt Expense
5.92M5.93M1.94M1.81M1.72M1.59M1.50M0.91M2.31M
Tax Rate
25.55%-19.06%-74.03%30.91%495.50%27.49%-87.96%95.17%261.91%-18.69%48.97%24.33%14.34%41.71%-102.90%-34.98%22.15%-115.99%-1.25%